5-13841051-AT-ATT
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001369.3(DNAH5):βc.5563_5564insAβ(p.Ile1855AsnfsTer6) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000601 in 1,613,974 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.000046 ( 0 hom., cov: 33)
Exomes π: 0.000062 ( 0 hom. )
Consequence
DNAH5
NM_001369.3 frameshift
NM_001369.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.45
Genes affected
DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 5-13841051-A-AT is Pathogenic according to our data. Variant chr5-13841051-A-AT is described in ClinVar as [Pathogenic]. Clinvar id is 407241.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH5 | NM_001369.3 | c.5563_5564insA | p.Ile1855AsnfsTer6 | frameshift_variant | 34/79 | ENST00000265104.5 | NP_001360.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH5 | ENST00000265104.5 | c.5563_5564insA | p.Ile1855AsnfsTer6 | frameshift_variant | 34/79 | 1 | NM_001369.3 | ENSP00000265104 | P4 | |
DNAH5 | ENST00000681290.1 | c.5518_5519insA | p.Ile1840AsnfsTer6 | frameshift_variant | 34/79 | ENSP00000505288 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152138Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
7
AN:
152138
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251182Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135746
GnomAD3 exomes
AF:
AC:
15
AN:
251182
Hom.:
AF XY:
AC XY:
9
AN XY:
135746
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000616 AC: 90AN: 1461836Hom.: 0 Cov.: 31 AF XY: 0.0000688 AC XY: 50AN XY: 727216
GnomAD4 exome
AF:
AC:
90
AN:
1461836
Hom.:
Cov.:
31
AF XY:
AC XY:
50
AN XY:
727216
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152138Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74320
GnomAD4 genome
AF:
AC:
7
AN:
152138
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
74320
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Primary ciliary dyskinesia 3 Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University Hospital Muenster | Jan 25, 2022 | ACMG categories: PVS1,PM3,PP5 - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2002 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Prenatal Genetic Diagnosis Laboratory, The Chinese University of Hong Kong | Mar 25, 2021 | This variant c.5563dupA(p.I1855fs) creates a premature termination codon in exon 34, where nonsense-mediated decay is predicted to occur. The mechanism of pathogenicity in DNAH5 mutations appears to be bi-allelic loss of function [PMID: 16627867] (PVS1). This variant is extremely rare in the gnomAD database (PM2). It was previously reported in patients with primary ciliary dyskinesia and atrial and ventricular septal defects and found to be in trans configuration with another damaging variant or as a homozygote [PMID: 11788826, 28991257, 31118369, 31772028, 32622824] (PM3). It is interpreted as pathogenic according to ACMG/AMP guidelines. - |
Pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Mar 12, 2020 | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PP1,PP3. - |
Pathogenic, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Oct 22, 2021 | DNAH5 c.5563dupA has been reported in multiple individuals with primary ciliary dyskinesia. This variant (rs752925056) is rare (<0.1%) in a large population dataset (gnomAD: 17/282580 total alleles; 0.006%; no homozygotes) and has been reported in ClinVar. This frameshift variant results in a premature stop codon in exon 34 likely leading to nonsense-mediated decay and lack of protein production. We consider DNAH5 c.5563dupA to be pathogenic. - |
Primary ciliary dyskinesia Pathogenic:3
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 19, 2022 | The c.5563dupA pathogenic mutation, located in coding exon 34 of the DNAH5 gene, results from a duplication of A at nucleotide position 5563, causing a translational frameshift with a predicted alternate stop codon (p.I1855Nfs*6). This alteration has been detected in the homozygous state, or in conjunction with another DNAH5 mutation, in multiple individuals with primary ciliary dyskinesia (Hornef N et al. Am J Respir Crit Care Med, 2006 Jul;174:120-6; Guo Z et al. J Pediatr, 2020 10;225:157-165.e5; Kurokawa A et al. Respir Investig, 2021 Jul;59:550-554; Blanchon S et al. J Med Genet, 2020 04;57:237-244; Raidt J et al. Eur Respir J, 2014 Dec;44:1579-88; Djakow J et al. Pediatr Pulmonol, 2016 May;51:498-509). In addition, this alteration has been found to cosegregate with disease in four affected homozygous siblings with consanguineous parentage (Olbrich H et al. Nat. Genet., 2002 Feb;30:143-4; Omran H et al. Am. J. Respir. Cell Mol. Biol., 2000 Nov;23:696-702). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | This sequence change creates a premature translational stop signal (p.Ile1855Asnfs*6) in the DNAH5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DNAH5 are known to be pathogenic (PMID: 11788826, 16627867). This variant is present in population databases (rs752925056, gnomAD 0.03%). This premature translational stop signal has been observed in individuals with primary ciliary dyskinesia (PMID: 11788826, 25186273, 26228299). ClinVar contains an entry for this variant (Variation ID: 407241). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at